Clinical Trials Browser

Phase 2 × Esophagogastric Cancer × Pemetrexed × Clear all

NCT02296671 2016-03-08

Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers

Phase 2 Withdrawn

Gastrointestinal

Esophagogastric Cancer